Mauna Kea Technologies News and Activities

Mauna Kea Technologies is a company listed under the stock ticker MKEA (FR).

View the org chart displaying its 10 main executives

Most searched biographies at Mauna Kea Technologies

• Sacha Loiseau, Chief Executive Officer and Chairman of the Board
• Molly O'Neill, Director
• Christopher McFadden, Director

Popular executive movements at Mauna Kea Technologies

• Jacquelien Ten Dam, Director, will leave the company on Jun. 4, 2026  (posted on May 19 2026).
• Claire Biot, Member of the Board, will leave the company on Jun. 4, 2026  (posted on May 19 2026).

Create your alert
to follow the executive moves at Mauna Kea Technologies.

Mauna Kea Technologies has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Mauna Kea Technologies

• Mauna Kea Technologies Receives NMPA Regulatory Approval in China for its Next-Generation Cellvizio® Platform  - Mauna Kea Technologies
• Mauna Kea Technologies Announces the Successful Completion of Its Financial Restructuring and €6M Capital Raise  - Mauna Kea Technologies
• Mauna Kea Technologies Exits Safeguard Proceedings Following Court Approval of its Plan and Initiates Minimum €5M Capital Raise  - Mauna Kea Technologies
• Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase  - Mauna Kea Technologies
• Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates  - Mauna Kea Technologies
• Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan  - Mauna Kea Technologies
• Mauna Kea Technologies Reaches a Key Milestone in Its Financial Restructuring  - Mauna Kea Technologies
• Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan - Mauna Kea Technologies
• Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion  - Mauna Kea Technologies
• Mauna Kea Technologies Unveils the Outlines of its Safeguard Plan to Ensure its Turnaround - Mauna Kea Technologies
• View more press releases Close

Social media about Mauna Kea Technologies

• Mauna Kea Technologies on Wikipedia, Google News & Yahoo Finance
• Mauna Kea Technologies on LinkedIn, X (Twitter) & YouTube